Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

33686 Results Found

Event

Data-driven Approaches to Improve Maternal Health Outcomes Webinar Replay

Actionable data is a key component of any successful initiative. In this virtual workshop, experts share best practices for collecting, evaluating and transforming data into action. Learn how hospitals are improving outcomes for maternal and child health through innovative, data-driven solutions, while reducing variation in care delivery.
News

Chair File: New Resources for Strong Mental Well-being

The outpouring of love, support and gratitude shown toward our magnificent health care workers has helped to keep them going in the strenuous battle against COVID-19. The gestures and praise for our health care heroes is a wonderful thing, and we must keep it up.
People

Shira Hollander

AHIA Page

Market Insights: Disruptive Innovation

Some of the nation’s most innovative companies have launched initiatives large and small to disrupt health care’s status quo. The aim: to deliver better health care in more cost-effective and efficient ways in locations that are easily accessible, affordable and more desirable for consumers to use. Large retailers and technology giants are playing a larger role in health care innovation with new models of consumer service and engagement, digital health technology and human interactions augmented with artificial intelligence. Scientific breakthroughs and technological advancements in precision diagnostics, precision medicine, patient monitoring, and drug discovery and delivery for targeted therapies are paving the way for patient-centric care and a shift from the field’s focus on illness to sustaining health and well-being.
Fact Sheets

Fact Sheet: Protecting the Right to Organize (PRO) Act of 2021

The House of Representatives March 9 adopted the Protecting the Right to Organize (PRO) Act of 2021 (H.R. 842). A virtually identical bill is pending in the Senate (S. 420). If adopted by the Senate and signed by President Biden, the PRO Act would make sweeping changes to the National Labor Relations Act (NLRA) and other labor laws in the United States, including in ways that could have a significant adverse impact on hospitals and health systems as employers.
AHA Center for Health Innovation Market Scan

Study Finds New Commercial AI Devices Often Lack Key Performance Data

Enthusiasm for and adoption of commercial artificial intelligence (AI) tools to aid clinical decision-making and patient care have been accelerating at a rapid pace. A new study, though, cautions that critical information often is missing from the Food and Drug Administration (FDA) clearance process that could measure how these devices actually work in patient care.
AHA Center for Health Innovation Market Scan

Many Workers Have Yet to Get Mental Health Care They Need Due to Pandemic

Nearly one in five health care workers say they need mental health services due to the pandemic but have yet to seek care because they’re too busy, unable to get time off work, can’t afford it or are too afraid or embarrassed.
News

CDC reports 42% HIV rate in transgender women surveyed in 7 cities

Four in 10 transgender women surveyed in seven U.S. cities in 2019-2020 were HIV positive, including nearly two-thirds of African American/Black and one-third of Hispanic/Latina respondents, the Centers for Disease Control and Prevention reported.
News

AHA and Black Coalition Against COVID to host April 21 town hall

The AHA and Black Coalition against COVID April 21 at 7 p.m. ET will host a town hall on enhancing the opportunities for rural health care providers, public health organizations and rural health advocates as they advance COVID-19 prevention guidance, vaccine acceptance and vaccine administration. 
News

FDA revokes emergency use authorization for monoclonal antibody bamlanivimab

The Food and Drug Administration revoked the emergency use authorization that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients.